Synonyms: BC-3781 | BC3781 | compound 7 [PMID: 24874438] | Xenleta®
lefamulin is an approved drug (FDA (2019), EMA (2020))
Compound class:
Synthetic organic
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2019), EMA (2020)) |
International Nonproprietary Names | |
INN number | INN |
9849 | lefamulin |
Synonyms |
BC-3781 | BC3781 | compound 7 [PMID: 24874438] | Xenleta® |
Database Links | |
Specialist databases | |
Antibiotic DB | Lefamulin (BC-3781) |
Other databases | |
BindingDB Ligand | 50019649 |
CAS Registry No. | 1061337-51-6 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL3291398 |
DrugCentral Ligand | 5348 |
GtoPdb PubChem SID | 405560265 |
PubChem CID | 25185057 |
RCSB PDB Ligand | 62B |
Search Google for chemical match using the InChIKey | KPVIXBKIJXZQJX-FCEONZPQSA-N |
Search Google for chemicals with the same backbone | KPVIXBKIJXZQJX |
Search PubMed clinical trials | lefamulin |
Search PubMed titles | lefamulin |
Search PubMed titles/abstracts | lefamulin |
UniChem Compound Search for chemical match using the InChIKey | KPVIXBKIJXZQJX-FCEONZPQSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | KPVIXBKIJXZQJX-FCEONZPQSA-N |